Sustainable Development Goals
 |
 |
 |
 |
|
-
Target 3.8 | Achieve Universal Health Coverage
|
|
-
Target 3.9 | Reduce Illnesses and Death from Hazardous Chemicals and Pollution
|
|
|
|
|
-
Target 3.5 | Prevent and Treat Substance Abuse
|
|
|
-
Target 3.D | Improve Early Warning Systems for Global Health Risks
|
|
|
Targets and Indicators with Data Availability
Note: The data may be updated periodically as more information become available.
 |
Reduce Maternal Mortality
By 2030, reduce the global maternal mortality ratio to less than 70 per 100,000 live births.
|
Indicator 3.1.1 | Maternal mortality ratio
Indicator 3.1.2 | Proportion of births attended by skilled health personnel
 |
End All Preventable Deaths Under 5 Years of Age
By 2030, end preventable deaths of newborns and children under 5 years of age, with all countries aiming to reduce neonatal mortality to at least as low as 12 per 1,000 live births and under-5 mortality to at least as low as 25 per 1,000 live births.
|
Indicator 3.2.1 | Under-5 mortality rate
Figure for latest available year is preliminary.
Note: Residents comprise Singapore citizens and permanent residents.
|
|
Indicator 3.2.2 | Neonatal mortality rate
 |
Fight Communicable Diseases
By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases.
|
Indicator 3.3.1 | Number of new HIV infections per 1,000 uninfected population, by sex, age and key populations
Data refer to incidence rate of new HIV infections (per 1,000 resident population i.e. Singapore citizens and permanent residents).
Download Data and Metadata
(21 KB)
|
|
Indicator 3.3.2 | Tuberculosis incidence per 100,000 population
Data refer to incidence rate of new Tuberculosis infections (per 100,000 population) among Singapore residents and long staying foreigners.
Download Data and Metadata
(11 KB)
|
 |
Indicator 3.3.3 | Malaria incidence per 1,000 population
Data for indigenous malaria incidence rate (per 100,000 total population) are nil or negligible since 2010.

|
 |
Indicator 3.3.4 | Hepatitis B incidence per 100,000 population
 |
Reduce Mortality from Non-communicable Diseases and Promote Mental Health
By 2030, reduce by one third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being.
|
Indicator 3.4.2 | Suicide mortality rate
 |
Reduce Road Injuries and Deaths
By 2020, halve the number of global deaths and injuries from road traffic accidents.
|
Indicator 3.6.1 | Death rate due to road traffic injuries
 |
Universal Access to Sexual and Reproductive Care, Family Planning and Education
By 2030, ensure universal access to sexual and reproductive health-care services, including for family planning, information and education, and the integration of reproductive health into national strategies and programmes.
|
Indicator 3.7.2 | Adolescent birth rate (aged 10–14 years; aged 15–19 years) per 1,000 women in that age group
The corresponding data for females aged 10-14 years are nil or negligible.
|
|
 |
Implement the WHO Framework Convention on Tobacco Control
Strengthen the implementation of the World Health Organization Framework Convention on Tobacco Control in all countries, as appropriate.
|
Indicator 3.A.1 | Age-standardised prevalence of current tobacco use among persons aged 15 years and older
Note: Data refer to the daily smoking prevalence among aged 18 - 74 years for Singapore residents (i.e. Singapore citizens and permanent residents), age-standardized to WHO World Standard Population.
Download Data and Metadata
(12 KB)
|
|
 |
Support Research, Development and Universal Access to Affordable Vaccines and Medicines
Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all.
|
Indicator 3.B.2 | Total net official development assistance to medical research and basic health sectors
Not applicable. Singapore is a developing country and does not provide official development assistance. We undertake capacity building programmes on health related topics with other countries.
|
|
 |
Increase Health Financing and Support Health Workforce in Developing Countries
Substantially increase health financing and the recruitment, development, training and retention of the health workforce in developing countries, especially in least developed countries and small island developing States.
|
Indicator 3.C.1 | Health worker density and distribution